We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLCE:NASDAQChildren's Place, Inc. (The) Analysis

Data as of 2026-04-24 - not real-time

$3.37

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The Children’s Place trades at $3.37, well below its 20‑day SMA of $3.40 and 50‑day SMA of $3.69, signaling a bearish price bias. RSI sits near 47, indicating neutral momentum, while the MACD histogram is modestly positive but the MACD line remains above the signal, offering only a faint bullish hint. The stock’s volatility is extreme at 124% over the past 30 days and its beta exceeds 2, underscoring high price swings relative to the market. Fundamentals are weak: revenue fell 19% YoY, operating margin is negative 11%, and the company posted a $44.6 million Q4 loss with a trailing EPS of –$4.01. Debt stands at $514 million against a market cap of $75 million, creating a precarious balance sheet, and both PE and PB ratios are deeply negative. Despite a low price‑to‑sales multiple of 0.06, cash flow is thin and free cash flow is modest, offering limited cushion. The sector—consumer cyclical apparel—faces discretionary pressure, and the “Extreme Greed” market sentiment (Fear & Greed Index 88) may be inflating short‑term buying interest. No dividend is paid, eliminating income support. Overall, the stock is trading at a discount but carries significant operational and financial risk, suggesting caution for investors.
Given the bearish technical alignment, deteriorating earnings, and high volatility, short‑term exposure is risky, while a medium‑term hold could be justified if the company can stabilize its digital channel and improve cash conversion. Long‑term prospects remain uncertain without a clear turnaround strategy.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price below key moving averages
  • negative earnings and widening loss
  • high volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • low price‑to‑sales valuation
  • potential upside from omni‑channel strategy
  • ongoing cash flow constraints

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • significant balance‑sheet risk
  • uncertain turnaround path
  • industry exposure to discretionary spending

Key Metrics & Analysis

Financial Health

Revenue Growth-19.40%
Profit Margin-7.30%
P/E Ratio-1.7
ROA-4.67%
P/B Ratio-8.7
Op. Cash Flow$8.1M
Free Cash Flow$27.3M

Technical Analysis

TrendBearish
RSI46.8
Support$2.76
Resistance$4.40
MA 20$3.40
MA 50$3.69
MA 200$5.41
MACDBullish
VolumeIncreasing
Fear & Greed Index88.02

Valuation

Target Price$3.50
Upside/Downside3.86%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.23
Volatility123.60%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.